Indication

Pseudomonas aeruginosa osteomyelitis

Pseudomonas aeruginosa osteomyelitis is an acute or chronic inflammatory bone infection caused by the opportunistic Gram-negative bacillus Pseudomonas aeruginosa. Read more about Pseudomonas aeruginosa osteomyelitis

133 drugs 78 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa osteomyelitis therapies.

Showing 64–72 of 133 drugs

CEFTAZIDIME

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
SAGENT/PREMIERP
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa osteomyelitis.

Pseudomonas aeruginosa osteomyelitis is an acute or chronic inflammatory bone infection caused by the opportunistic Gram-negative bacillus Pseudomonas aeruginosa.

It primarily affects the skeletal system, commonly presenting after puncture wounds through footwear, contiguous spread from diabetic foot ulcers or invasive orthopedic procedures, and hematogenous seeding in vulnerable populations such as people who inject drugs or hospitalized individuals.

Pathophysiologically, the organism employs robust virulence factors—including tissue-degrading exoenzymes, endotoxins, and protective biofilms—leading to progressive vascular occlusion, localized bone destruction, and sequestrum formation, which often manifest as persistent bone pain, localized swelling, and sinus tract drainage.

Personalize your experience

Follow Pseudomonas aeruginosa osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it